tm logo
PURE-EXO
Live/Pending
FINAL REFUSAL - MAILED

mailed

on 18 Oct 2024

Last Applicant/ Owned by

40-20 Techno 6-ro, Yuseong-gu

Daejeon

KR

34014

Serial Number

90357314 filed on 03rd Dec 2020

Registration Number

N/A

Correspondent Address

Janice Housey

Janice Housey Litmus Law PLLC

Winchester, VA 22601

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

PURE-EXO

Biotechnology research; technological research in the field of cell biology; laboratory research in the field of cell biology; pharmaceutical drug development services; genetic testing for scientific research purposes; research in the field of chemistry; drug discovery services; medical research and development services; pharmaceutical research and development services; biopharmaceutical research Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Biotechnology research; technological research in the field of cell biology; laboratory research in the field of cell biology; pharmaceutical drug development services; genetic testing for scientific research purposes; research in the field of chemistry; drug discovery services; medical research and development services; pharmaceutical research and development services; biopharmaceutical research and development services


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; drug delivery agents for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications; extracellular vesicles for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biochemicial drug for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; reagents for use in medical genetic testing; diagnostic reagents for medical use; biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological reagents for clinical medical use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Biological preparations, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; proteins for the food industry; chemical reagents, other than for medical or veterinary purpose


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 90357314

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
23rd Oct 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21st Oct 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21st Oct 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
21st Oct 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21st Oct 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21st Oct 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
18th Oct 2024FINAL REFUSAL WRITTEN
18th Oct 2024FINAL REFUSAL E-MAILED
18th Oct 2024NOTIFICATION OF FINAL REFUSAL EMAILED
24th Jun 2024ASSIGNED TO LIE